Dr. Liao reviews his teams research on comparing the efficacy of biologic and oral treatments in PP and PPP.
Dr. Tsoi discusses his research on the effects Ixekizumab and Guselkumab has on IL-17/IL-23 pathway gene expression in psoriasis lesions.
Dr. Conrad discusses whether we can now modify the course of the disease or at least prevent the need for
Dr. Gudjonsson reviews his teams research on the impact of treatment with Secukinumab on DNA methylation patterns in the skin
Dr. Braun reviews her research on antigens that can trigger immune responses in psoriasis patients.
Dr. Ghaffarinia discusses her research on the difference between psoriatic never-lesional and resolved keratinocyte skin.
Dr. Eidsmo reviews how epigenetic inflammation sets the stage for T cell based disease memories.
